However, during the SARS-CoV-2 pandemic, the hSAB-NS1.1 cell line was proposed as suitable for infection studies because it was shown to contain the spike protein angiotensin-converting enzyme 2 (ACE2) in differentiated cell types. This evidence concerns the gene ACE2 and infection.